家庭监测能否实现青光眼快速视野进展的早期检测?
研究通过计算机模拟(参数经43例接受治疗青光眼、高眼压或可疑青光眼患者队列验证)比较家庭监测与门诊复查对快速视野缺损(MD年损失-2 dB)的检测灵敏度。结果显示周家庭监测在0.9年即达灵敏度0.8,而6月门诊监测需2.5年。作者认为家庭监测策略可能改善快速视野进展检测,但成本效益尚未证实。
要点
- 周家庭监测在0.9年达到检测快速视野进展的灵敏度0.8,而6月门诊监测需2.5年。
- 即使家庭监测依从性仅63%或测试变异增大,周家庭监测仍优于6月门诊监测。
- 家庭监测策略可能改善快速视野进展检测,但其成本效益尚未证实。
核心结论
- 使用家庭监测策略可能改善快速视野进展的检测,即使依从性不完美也是如此。
- 然而,这种方法的成本效益尚未证实。
研究设计与样本
- 计算机模拟研究,参数选择经队列研究确认。
- 队列研究纳入43例接受治疗青光眼(开角型和闭角型)、高眼压或可疑青光眼患者(平均年龄71岁,范围37-89岁),用于在2个月时测量家用设备的重测变异以确认已发表的视野变异特征适用于家庭监测设备。
- 模拟了稳定青光眼和进展性青光眼患者的视野序列(n=100 000),涵盖2种门诊复查方案(每年和每6个月)及3种家庭监测方案(每月、每两周和每周),各运行5年。
- 通过随机省略不同比例的家庭监测视野来模拟依从性降低,并操控家庭监测视野的变异。
- 模拟中判定进展的标准为模拟患者平均偏差(MD)数据普通最小二乘回归的显著斜率。
主要发现
- 6个月门诊检测在2.5年后对快速视野损失(MD年损失-2 dB)达到灵敏度0.8。
- 每周家庭监测在0.9年即达到灵敏度0.8,尽管测试依从性为中等水平63%。
- 即使假设家庭监测产生更大的测试变异或与低患者依从性相关,每周家庭监测优于6个月门诊检测的性能仍然保持。
关键数值与推荐
- 模拟中判定进展的标准为模拟患者平均偏差(MD)数据普通最小二乘回归的显著斜率。
- 主要结局指标为识别快速视野损失(MD年损失-2 dB)的灵敏度。
- 每周家庭监测在依从性63%时于0.9年达到灵敏度0.8,而6个月门诊检测需2.5年达到灵敏度0.8。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文指出该方法的成本效益尚未证实。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Recent developments in electronic technology are making it possible to home monitor the sensitivity of the central visual field using portable devices. We used simulations to investigate whether the higher test frequency afforded by home monitoring improves the early detection of rapid visual field loss in glaucoma and how any benefits might be affected by imperfect compliance or increased variability in the home-monitoring test. DESIGN: Computer simulation, with parameter selection confirmed with a cohort study. PARTICIPANTS: A total of 43 patients with treated glaucoma (both open-angle and closed-angle), ocular hypertension or glaucoma suspects (mean age, 71 years; range, 37-89 years), were followed in the cohort study. METHODS: We simulated series (n = 100 000) of visual fields for patients with stable glaucoma and patients with progressing glaucoma for 2 in-clinic (yearly and 6-monthly) and 3 home-monitoring (monthly, fortnightly, and weekly) schedules, each running over a 5-year period. Various percentages of home-monitored fields were omitted at random to simulate reduced compliance, and the variability of the home monitored fields also was manipulated. We used previously published variability characteristics for perimetry and confirmed their appropriateness for a home-monitoring device by measuring the device's retest variability at 2 months in a cohort of 43 patients. The criterion for flagging progression in our simulation was a significant slope of the ordinary least squares regression of a simulated patient's mean deviation (MD) data. MAIN OUTCOME MEASURES: The sensitivity for identifying rapid visual field loss (-2 decibels [dB]/year loss of MD). RESULTS: Although a sensitivity of 0.8 for rapid field loss was achieved after 2.5 years of 6-monthly testing in the clinic, weekly home monitoring achieved this by 0.9 years despite moderate test compliance of 63%. The improved performance of weekly home monitoring over 6-monthly clinical testing was retained even when home monitoring was assumed to produce more variable test results or be associated with low patient compliance. CONCLUSIONS: Detecting rapid visual field progression may be improved using a home-monitoring strategy, even when compliance is imperfect. The cost-benefit of such an approach is yet to be demonstrated, however.
引用
- Anderson AJ, Bedggood PA, George Kong YX, et al. Can Home Monitoring Allow Earlier Detection of Rapid Visual Field Progression in Glaucoma? Ophthalmology. 2017. PMID: 28764889. doi:10.1016/j.ophtha.2017.06.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。